KRAS G12C Mutations with Dr. Tetsuya Mitsudomi

Episode
64
Soundcloud
Share

This episode of Lung Cancer Considered covers recent promising results with new targeted agents for NSCLC harboring a KRAS G12C mutation. Thoracic oncologists have long thought this condition was undruggable, but results presented at WCLC 2020 from the CodeBreak 100 trial provide hope that new therapies will be more readily available.

Guest
Dr. Tetsuya Mitsudomi
Dr. Tetsuya Mitsudomi

MD, PhD

Professor at the Division of Thoracic Surgery
Kindai University
Stephen Liu, MD
Dr. Stephen Liu

MD

Georgetown University

Other Podcast

Dr. Eddie Garon
Episode
65
Tumor Board Discussion: Mesothelioma
Episode
63
ELCC Podcast
Episode
61